Silicosis future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Silicosis}} {{CMG}} ==Overview== Silicosis is an irreversible condition with no cure. Treatment options currently focus on alleviating the symptoms and preventin...")
 
Line 20: Line 20:
   | accessdate =  
   | accessdate =  
   | quote = Previously it was shown that the action of tetrandrine is attributed to its ability to inhibit the release of reactive oxygen metabolites and inflammatory cytokines by alveolar macrophages, and that targeted delivery of tetrandrine to alveolar macrophages using a multiple emulsion system minimizes drug toxicity, maintains the drug's pharmacological activity, and enhances tetrandrine distribution in the lungs while reducing systemic drug distribution. This study provides ''in vivo'' evidence of emulsion-mediated enhancement of drug action in the lungs against silica-induced lung injury using a rat model. }}</ref>
   | quote = Previously it was shown that the action of tetrandrine is attributed to its ability to inhibit the release of reactive oxygen metabolites and inflammatory cytokines by alveolar macrophages, and that targeted delivery of tetrandrine to alveolar macrophages using a multiple emulsion system minimizes drug toxicity, maintains the drug's pharmacological activity, and enhances tetrandrine distribution in the lungs while reducing systemic drug distribution. This study provides ''in vivo'' evidence of emulsion-mediated enhancement of drug action in the lungs against silica-induced lung injury using a rat model. }}</ref>
==References==
==References==



Revision as of 19:27, 17 June 2015

Silicosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Silicosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Silicosis future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Silicosis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Silicosis future or investigational therapies

CDC on Silicosis future or investigational therapies

Silicosis future or investigational therapies in the news

Blogs on Silicosis future or investigational therapies

Directions to Hospitals Treating Silicosis

Risk calculators and risk factors for Silicosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Silicosis is an irreversible condition with no cure. Treatment options currently focus on alleviating the symptoms and preventing complications.

Future or Investigational Therapies

Experimental treatments include:

  • Whole-lung lavage (see Bronchoalveolar lavage)
  • Inhalation of powdered aluminium, d-penicillamine and polyvinyl pyridine-N-oxide.
  • Corticosteroid therapy.
  • The herbal extract tetrandine may slow progression of silicosis.[1]

References

Template:WH Template:WS